According to a pivotal trial, the investigational endoscopic procedure duodenal mucosal resurfacing (DMR) may safely and effectively prevent weight regain following tirzepatide, a glucagon-like peptide-1 (GLP-1) therapy, withdrawal
Some people notice changes in energy sooner, especially if correcting a deficiency
These results suggest that the five core genes may represent two partially opposite expression patterns rather than a single redundant co-expression module ( Supplementary Figure 1 )
Its involvement in cancer biology has been already described so much that it can be accounted as a prognostic biomarker of different tumors [24, 25]
It is the compound studied in the STEP weight-management trials and is dispensed either as an FDA-approved branded product or, in the telehealth context, as a compounded preparation from a 503A pharmacy
Knowing how to store it properly can improve its effectiveness and guarantee safety